Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71201 - 71225 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	IRX3	79191	upregulated	Silicon Dioxide analog results in increased expression of IRX3 mRNA	16q12.2	A24194
Silicon dioxide	Approved	IRX4	50805	upregulated	Silicon Dioxide analog results in increased expression of IRX4 mRNA	5p15.33	A24194 A24195
Silicon dioxide	Approved	ISG15	9636	upregulated	Silicon Dioxide analog results in increased expression of ISG15 mRNA	1p36.33	A24195
Silicon dioxide	Approved	ISG20	3669	downregulated	Silicon Dioxide analog results in decreased expression of ISG20 mRNA	15q26.1	A24195
Silicon dioxide	Approved	ISG20	3669	upregulated	Silicon Dioxide results in increased expression of ISG20 mRNA	15q26.1	A24197 A24196
Silicon dioxide	Approved	ISL1	3670	downregulated	Silicon Dioxide analog results in decreased expression of ISL1 mRNA	5q11.1	A24195
Silicon dioxide	Approved	ITGA11	22801	downregulated	Silicon Dioxide analog results in decreased expression of ITGA11 mRNA	15q23	A24195
Silicon dioxide	Approved	ITGA2	3673	upregulated	Silicon Dioxide analog results in increased expression of ITGA2 mRNA	5q11.2	A24195
Silicon dioxide	Approved	ITGA3	3675	upregulated	Silicon Dioxide analog results in increased expression of ITGA3 mRNA	17q21.33	A24195
Silicon dioxide	Approved	ITGA5	3678	upregulated	Silicon Dioxide analog results in increased expression of ITGA5 mRNA	12q13.13	A24195
Silicon dioxide	Approved	ITGA8	8516	upregulated	Silicon Dioxide analog results in increased expression of ITGA8 mRNA	10p13	A24194
Silicon dioxide	Approved	ITGAL	3683	downregulated	Silicon Dioxide analog results in decreased expression of ITGAL mRNA	16p11.2	A24195
Silicon dioxide	Approved	ITGAM	3684	upregulated	Silicon Dioxide analog results in increased expression of ITGAM mRNA	16p11.2	A24195
Silicon dioxide	Approved	ITGAX	3687	upregulated	Silicon Dioxide analog results in increased expression of ITGAX mRNA	16p11.2	A24195
Silicon dioxide	Approved	ITGB1BP1	9270	upregulated	Silicon Dioxide analog results in increased expression of ITGB1BP1 mRNA	2p25.1	A24195
Silicon dioxide	Approved	ITGB1BP2	26548	upregulated	Silicon Dioxide analog results in increased expression of ITGB1BP2 mRNA	Xq13.1	A24195
Silicon dioxide	Approved	ITGB2	3689	downregulated	Silicon Dioxide analog results in decreased expression of ITGB2 mRNA	21q22.3	A24195
Silicon dioxide	Approved	ITGB3	3690	upregulated	Silicon Dioxide analog results in increased expression of ITGB3 mRNA	17q21.32	A24195
Silicon dioxide	Approved	ITGB5	3693	upregulated	Silicon Dioxide results in increased expression of ITGB5 mRNA	3q21.2	A24196
Silicon dioxide	Approved	ITGB6	3694	downregulated	Silicon Dioxide analog results in decreased expression of ITGB6 mRNA	2q24.2	A24195
Silicon dioxide	Approved	ITGBL1	9358	upregulated	Silicon Dioxide analog results in increased expression of ITGBL1 mRNA	13q33.1	A24195
Silicon dioxide	Approved	ITIH2	3698	downregulated	Silicon Dioxide analog results in decreased expression of ITIH2 mRNA	10p14	A24195
Silicon dioxide	Approved	ITLN1	55600	downregulated	Silicon Dioxide analog results in decreased expression of ITLN1 mRNA	1q23.3	A24195
Silicon dioxide	Approved	ITLN1	55600	upregulated	Silicon Dioxide analog results in increased expression of ITLN1 mRNA	1q23.3	A24194
Silicon dioxide	Approved	ITLN2	142683	upregulated	Silicon Dioxide analog results in increased expression of ITLN2 mRNA	1q23.3	A24194 A24195

Displaying entries 71201 - 71225 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability